Literature DB >> 5100077

Continuous norethindrone, 0.35 mg., as an oral contraceptive agent.

J A Board.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5100077     DOI: 10.1016/0002-9378(71)90624-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  6 in total

1.  Effect of long term use of oral contraceptives on glucose tolerance.

Authors:  B R Muck
Journal:  Arch Gynakol       Date:  1976-03-05

Review 2.  Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

3.  Effect of norethisterone on puerperal vaginal bleeding.

Authors:  H M Murphy
Journal:  Ir J Med Sci       Date:  1980-11       Impact factor: 1.568

4.  [Effect of oral contraceptives on plasma insulin and blood glucose levels after long term use (author's transl)].

Authors:  B R Muck; G Hommel
Journal:  Arch Gynakol       Date:  1976

5.  Effect of protease inhibitors on steady-state pharmacokinetics of oral norethindrone contraception in HIV-infected women.

Authors:  Jessica Atrio; Frank Z Stanczyk; Michael Neely; Ganesh Cherala; Andrea Kovacs; Daniel R Mishell
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

6.  A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimen.

Authors:  Thomas Kimble; Anne E Burke; Kurt T Barnhart; David F Archer; Enrico Colli; Carolyn L Westhoff
Journal:  Contracept X       Date:  2020-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.